Results 281 to 290 of about 676,672 (336)
Some of the next articles are maybe not open access.

Secondary metabolites from Ganoderma

Phytochemistry, 2015
Ganoderma is a genus of medicinal mushrooms. This review deals with secondary metabolites isolated from Ganoderma and their biological significance. Phytochemical studies over the last 40years led to the isolation of 431 secondary metabolites from various Ganoderma species. The major secondary compounds isolated are (a) C30 lanostanes (ganoderic acids),
Sabulal Baby   +2 more
openaire   +4 more sources

Secondary Metabolites

2011
Microbial secondary metabolites are low-molecular-mass products of secondary metabolism, usually produced during the late growth phase (idiophase) of microorganisms. They have unusual structures and their production arises from intracellular intermediates (amino acids, sugars, fatty acids, etc.), which are condensed into more complex structures by ...
S. Sanchez, A.L. Demain
openaire   +2 more sources

Transporters of secondary metabolites

Current Opinion in Plant Biology, 2005
The membrane transport of plant secondary metabolites is a newly developing research area. Recent progress in genome and expressed sequence tag (EST) databases has revealed that many transporters and channels exist in plant genome. Studies of the genetic sequences that encode these proteins, and of phenotypes caused by the mutation of these sequences ...
openaire   +3 more sources

Plant Secondary Metabolites

2015
Secondary metabolites are those compounds which are produced by certain microorganisms in a phase of subsequent to growth, may have some survival function, have unusual chemical structures, and are formed as mixtures of closely related members of a chemical family.
openaire   +2 more sources

Extraction of Plant Secondary Metabolites

2006
This chapter presents an overview of the preparation of extracts from plants using organic solvents, with emphasis on common problems encountered and methods for their reduction or elimination. In addition to generally applicable extraction protocols, methods are suggested for selectively extracting specific classes of plant-derived compounds, and ...
A. Douglas Kinghorn, William P. Jones
openaire   +3 more sources

Production of Secondary Metabolites by Bioconversion

2007
The omnipotency (omnis = all, potens = powerful) of the plant cell implies that all genetic information present in the plant is principally available in each cell. This means that genes encoding enzymes that belong to biosynthetic pathways can be brought to expression.
Pras, Niesko, Woerdenbag, Herman J.
openaire   +4 more sources

Production of Secondary Metabolites

1993
The application of present-day technology to the production of antibiotics and other secondary metabolites began with the common effort that academic and industrial institutions made, in the early 1940s, in response to the urgent need for large-scale production of the newly discovered penicillin.
Rolando Lorenzetti, Giancarlo Lancini
openaire   +2 more sources

Ectomycorrhiza and Secondary Metabolites

2010
Ectomycorrhizal symbiosis leads to the diversification of both the mycobiont and their host. Differences in organogenetic programs are reflected in ectomycorrhizal root morphology, but key developmental programs are triggered in the physiological processes in both symbiosis partners and are dependent on hormones and secondary signals.
Patrycja Golińska, Hanna Dahm
openaire   +2 more sources

Toxicity of secondary metabolites

Physical Sciences Reviews, 2019
Abstract Secondary metabolites, commonly referred to as natural products, are produced by living organisms and usually have pharmacological or biological activities. Secondary metabolites are the primary source for the discovery of new drugs. Furthermore, secondary metabolites are also used as food preservatives, biopesticides or as research tools ...
Ricardo Bruno Hernández-Alvarado   +4 more
openaire   +2 more sources

Molecular recognition by secondary metabolites

Biochemical Pharmacology, 1990
Aspects of molecular recognition based on the interaction between the vancomycin group of antibiotics and bacterial cell wall precursor analogues are discussed. The energetically unfavourable folding-in of the residue 1 sidechain in vancomycin and ristocetin A is discussed in terms of the favourable entropy associated with simultaneous release of ...
Russell J. Mortishire-Smith   +3 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy